Svetlana Lucas
Director/Board Member at ATYR PHARMA, INC.
Net worth: 10 380 $ as of 2024-05-30
Svetlana Lucas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATYR PHARMA, INC. | Director/Board Member | 2019-06-27 | - |
| Independent Dir/Board Member | 2019-06-27 | - | |
| JASPER THERAPEUTICS, INC. | Director/Board Member | 2024-06-18 | - |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - | - |
Career history of Svetlana Lucas
Former positions of Svetlana Lucas
| Companies | Position | Start | End |
|---|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2015-06-30 | 2019-05-31 |
| AMGEN INC. | Corporate Officer/Principal | 2014-07-31 | 2015-06-30 |
Training of Svetlana Lucas
| California Institute of Technology | Doctorate Degree |
| Moscow State University Lomonosov | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Russia | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Private companies | 2 |
|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Svetlana Lucas
- Experience
